![Sang-Hoon Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sang-Hoon Lee
Fondateur chez
ABL BIO INC.
Fortune : 815 M $ au 30/06/2026
Profil
Sang-Hoon Lee is the founder.
Dr. Lee was the Executive Vice President at PharmAbcine Inc. since 2008.
Dr. Lee is the Chief Executive Officer & Director at ABL Bio, Inc. since 2016.
Education includes a doctorate from The Ohio State University and undergraduate and graduate degrees from Seoul National University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABL BIO, INC. 22,67% | 13/07/2026 | 12 690 000 ( 22,67% ) | 815 M $ | 30/06/2026 |
Postes actifs de Sang-Hoon Lee
| Sociétés | Poste | Début |
|---|---|---|
| ABL BIO INC. | Fondateur | 16/02/2016 |
Anciens postes connus de Sang-Hoon Lee
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMABCINE INC. | Fondateur | 01/01/2013 |
Formation de Sang-Hoon Lee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmAbcine Inc.
 PharmAbcine Inc. BiotechnologyHealth Technology Develops human therapeutic monoclonal antibody for the treatment of cancer and inflammatory diseases | Health Technology |
ABL Bio, Inc.
 ABL Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of therapeutic drugs | Health Technology |
